Associations of virulence genotype and phylogenetic background with epidemiological factors (primary source of bacteremia, host compromise status, and hospital versus community origin) were assessed among 182 Escherichia coli blood isolates from adults with diverse-source bacteremia in comparison with fecal controls from the E. coli Reference collection. A continuum of virulence was found, from urinary and pulmonary source bacteremia isolates (high virulence), through "other" or unknown source bacteremia isolates (intermediate virulence), to fecal isolates (low virulence), with a corresponding graded phylogenetic distribution from predominantly group B2 to predominantly groups A and B1. Associations of bacterial traits with clinical factors varied considerably, depending on subgroup and statistical method. However, certain putative virulence genes (including several "nontraditional" markers, such as pathogenicity island-associated malX ) repeatedly emerged as significant epidemiological predictors, which provided evidence of their possible relevance in host-pathogen interactions and hence as potential targets for preventive interventions against extraintestinal infections due to E. coli.
Extraintestinal infections due to Escherichia coli are a major source of morbidity, mortality, and increased health care costs [1] [2] [3] [4] . For example, as the principal cause of urinary tract infections (UTIs), E. coli presumably is responsible for most of the 6.7 million physician visits for UTI symptoms and the 1.6 million hospital discharges involving a diagnosis of UTI that occur annually in the United States [5] . E. coli also causes 36,000 fatal cases of severe sepsis annually in the United States [3, 6, 7] . Clearly, better preventive measures are needed against these infections.
Most such infections are due to distinctive strains of E. coli that have an enhanced ability to cause extraintestinal disease by virtue of their specialized virulence factors (e.g., adhesins, polysaccharide coatings, siderophores, serum resistance elements, and toxins), which help overcome or subvert host defenses, injure or invade host tissues, and incite a noxious inflammatory response [1, 8, 9] . Such strains, for which the inclusive designation "extraintestinal pathogenic E. coli" (ExPEC) has been proposed because of their pathogenic versatility with respect to host population, anatomical site, and clinical syndrome, derive predominantly from E. coli phylogenetic group B2 [10, 11] . In contrast, diarrheagenic E. coli variants have evolved primarily within E. coli phylogenetic groups A, B1, and D, and most commensal fecal E. coli derive from phylogenetic groups A and B1. Although the phylogenetic group B2 genomic background appears to have a special affinity for the specialized virulence factors that underlie the extraintestinal virulence of ExPEC, the relevant virulence factors can enter other lineages through horizontal transfer, thereby converting the recipient strains to potential pathogens [12] [13] [14] .
Molecular epidemiological studies, in which bacterial traits are compared with host characteristics, can guide the development of the needed preventive measures against extraintestinal E. coli infections by helping to identify relevant bacterial targets for vaccines and other protective interventions and by delineating appropriate host populations for their deployment [8, [15] [16] [17] [18] [19] [20] [21] [22] . We have reported elsewhere the results of an extensive combined pathotypic and clonal analysis of a large collection of E. coli blood isolates from adult patients with diverse-source E. coli bacteremia [23] . In the present study, we compared these bacterial data with epidemiological data derived elsewhere from the same population [18] . Specifically, we used diverse statistical methods to identify associations among bacterial characteristics, including putative virulence factors and phylogenetic group, and clinical factors, including primary source of bacteremia, host compromise status, and hospital versus community acquisition of infection.
Materials and Methods
Strains. The population of isolates we studied included 182 of the original 187 E. coli blood isolates recovered from adult patients with diverse-source E. coli bacteremia in Boston, Massachusetts, Long Beach, California, and Nairobi, Kenya, during the 1980s, as reported elsewhere [18, 24] .
Virulence genotypes and phylogenetic data. The 182 bacteremia isolates have been characterized elsewhere for diverse virulence-associated genes (VGs) of ExPEC-including those encoding a variety of adhesins, toxins, siderophores, capsule variants, serum resistance factors, invasins, and miscellaneous other traits (as listed in table 1)-through a combination of probe hybridization and polymerase chain reaction-based assays [18, [23] [24] [25] . Specific probes or primers were used to separately detect the F1C and S fimbrial adhesin genes, the 3 alleles of the P fimbrial adhesin gene (papG), and the 12 alleles of the P fimbrial structural subunit gene (papA) [23, 26, 27 ]. An aggregate VG score was calculated for each isolate as the sum of all VGs for which the isolate tested as positive, after adjustment for multiple detection of the same operon [23] . A "modified aggregate VG score" that was limited to those VGs for which data were available from our laboratory (J.R.J.) for both the present collection and the E. coli reference (ECOR) collection [28] also was calculated, to allow for comparisons between the present study population and the 29 members of the ECOR collection that are fecal isolates from healthy humans. These includes ECOR strains 1, 2, 4-6, 8-10, 12, 13, 15, 24, 26, 28, 35, 36, 38, 39, 41-43, 49, 51, 53, 54, 56, 59 , 61, and 63 [29] , which derive from E. coli phylogenetic groups A (n ¼ 12), B1 (n ¼ 2), B2 (n ¼ 7), or D (n ¼ 6) or are ungrouped (n ¼ 2) [30] .
Phylogenetic relationships within the present collection have been defined according to multilocus enzyme electrophoresis (MLEE) [24] , whereas correspondence between the major MLEE-defined phylogenetic clusters of this collection and those of the ECOR collection have been established by use of random amplified polymorphic DNA (RAPD) analysis [23] . In brief, several representatives of each the 4 major clusters of the present collection were amplified in parallel with representatives of each the 4 major phylogenetic groups and the ungrouped strains of the ECOR collection, with the use of several RAPD primers for each strain. Similarity relationships between the reference bacteremia isolates and the ECOR strains, based on composite RAPD profiles, as assessed objectively by a computerized gel analysis system, were used to assign each of the reference bacteremia isolates to an ECOR phylogenetic group. From these assignments, the ECOR equivalent of each of the major clusters of the present collection was inferred [23] .
Epidemiological data. Epidemiological data for the study subjects were extracted from medical records, as reported elsewhere [18, 24] . The primary source of bacteremia (urinary tract, n ¼ 85; pulmonary, n ¼ 12; genital tract or prostate, n ¼ 7; gastrointestinal/ abdominal, n ¼ 40; neutropenia, n ¼ 7; miscellaneous, n ¼ 6; and unknown, n ¼ 25) was defined on the basis of the clinical presentation and the results of cultures from other body sites. Local compromise (n ¼ 73) was defined as a significant anatomical or physiological abnormality at the site of primary infection (if known). Alcoholism (n ¼ 39) was defined as evidence of significant medical complications from alcohol use, with ongoing use. Immune defects (n ¼ 63) included AIDS, advanced malignancy, end-stage renal disease, and NOTE. Data are no. (%) of isolates. afa/dra, Dr-binding adhesins; bma, M fimbriae; cdtB, cytolethal distending toxin; cnf1, cytotoxic necrotizing factor 1; cvaC, colicin V; focG, F1C fimbriae; fyuA, yersiniabactin receptor; hly, hemolysin; ibeA, invasion of brain endothelium A; iha, putative adhesin-siderophore; iroN, putative catecholate siderophore receptor; iut, aerobactin; K1, K1 kpsMT II variant; "K2," putative K2 kpsMT II variant; kpsMT II and III, group II and group III capsule synthesis; malX, marker for pathogenicity-associated island from strain CFT073; nfa, nonfimbrial adhesins; papA, P fimbriae structural subunit, with variants F7-1 through F16; papG, P fimbrial adhesin molecule, with variants I, II, and III; sfa/foc, S and F1C fimbriae; sfaS, S fimbrial adhesin; traT, serum-resistance associated outer membrane protein.
a Virulence genotype data are as reported elsewhere [23] [24] [25] . b Shown only for comparisons that yielded P < :01. Parentheses indicate negative associations with urinary tract or pulmonary source.
c The letter in parentheses indicates the method by which the VG was determined (b, by blot; p, by polymerase chain reaction). medical immunosuppressive therapy. "Any compromise" (n ¼ 118) included any of the above compromising conditions. Communityacquired infections (n ¼ 114) were defined as those with symptom onset prior to or within 48 h of hospital admission in patients who had not been hospitalized during the preceding 30 days, whereas hospital-acquired infections (n ¼ 67) were defined as those with symptom onset >48 h after hospital admission.
Statistical methods. [31] . Comparisons of VG scores were tested by use of the Mann-Whitney U test. Stepwise multivariate logistic regression analysis was used to identify bacterial variables that independently predicted selected host outcome variables and to estimate odds ratios (ORs). Except for the comparison of phylogenetic group versus clinical source of bacteremia, for which P , :05 was considered to be significant (table 2), the threshold for statistical significance throughout was P < :01, with :01 , P , :05 regarded as reflecting borderline significance.
Results
Primary source of bacteremia. Virulence genotype and phylogenetic background first were analyzed in relation to the primary source of bacteremia (number of isolates in group)-urinary (85), genital/ prostate (7), gastrointestinal/ abdominal (40), pulmonary (12), neutropenia-associated (7), miscellaneous (6), and unknown (25) . When compared directly, the urinary and pulmonary source isolates were quite similar with respect to VG profiles, differing by a median of only 7% with respect to the absolute prevalence of any of the VGs analyzed (data not shown). Only 1 such comparison yielded P , :05 (i.e., the F15 papA allele: 1/85 urinary vs. 2/12 pulmonary; P ¼ :04). Aggregate VG scores were similar in the 2 groups (median, 8.0 for urinary vs. 8.75 for pulmonary; P . :10). Likewise, 78 (80%) of the urinary source isolates and all 12 pulmonary source isolates were from phylogenetic cluster III (group B2 equivalent) (P . :10). Of interest, 6 (50%) of the pulmonary source isolates were community-acquired, and 3 were from noncompromised hosts. In consequence, the urine and pulmonary source isolates were combined for further analysis (n ¼ 97). Similarly, the various nonurine, nonpulmonary source clinical groups exhibited minimal between-group differences with respect to VG prevalence and phylogenetic distribution (data not shown) and hence also were combined for further analysis (n ¼ 85).
The combined urine and pulmonary source isolates exhibited a significantly higher prevalence of multiple VGs, compared with all other isolates combined. VGs that were significantly more prevalent among the urine and pulmonary source isolates included papA (specifically the F7-2 and F16 papA alleles), papG (specifically papG allele II), hly (hemolysin), cnf1 (cytotoxic necrotizing factor 1), fyuA (yersiniabactin receptor), and malX (marker for pathogenicity-associated island [PAI] from strain CFT073) (table 1) . Similar trends were seen for papG allele III, the papG allele II + III combination, sfa/foc (S and F1C fimbriae), iha (putative adhesin-siderophore), iroN (putative catecholate siderophore receptor), and kpsMT II (group II capsule synthesis) (data not shown; :01 , P , :05 for all). In contrast, only the F8 papA allele was significantly more prevalent among the "other source" isolates (table 1) . Accordingly, aggregate VG scores were significantly greater among the urine and pulmonary source isolates than among the other isolates (median, 7.2 vs. 4.9; P , :001). Likewise, the urine and pulmonary source isolates were significantly more likely than other isolates to derive from cluster III (ECOR phylogenetic group B2 equivalent, as defined by RAPD analysis) and significantly less likely to derive from clusters I or IV (ECOR phylogenetic groups A and B1 equivalents, respectively) (table 2).
The virulence genotype and phylogenetic data next were subjected to stepwise multivariate logistic regression analysis, in which cluster of origin was included as a predictor variable (table  3) . The 2 bacterial characteristics that were significant independent predictors of urine or pulmonary origin were papG and cluster III origin. Similar trends were observed for absence of focG (F1C fimbriae) and presence by blot of kpsMT II (data not shown; both :01 , P , :05).
Comparison with fecal controls. Notwithstanding the pathotypic and phylogenetic differences between the urine and pulmonary source bacteremia isolates versus the "other source" bacteremia isolates, each of these source groups exhibited a higher prevalence of multiple VGs than did the 29 human fecal isolates from the ECOR collection, which served as controls [28, 29] . The urine and pulmonary source bacteremia isolates differed significantly from the ECOR controls specifically for papA, papG, sfa/foc, focG, hly, iroN, kpsMT II, and malX (all P < :01) and exhibited similar borderline trends for papG allele II, sfaS (S fimbrial adhesin), cnf, and fyuA (data not shown; all :01 , P , :05). Likewise, although the "other source" bacteremia isolates did not differ from the ECOR controls at the P < :01 level, they exhibited borderline trends toward a higher prevalence of focG, iroN, kpsMT II, and malX (data not shown; all :01 , P , :05). Aggregate VG scores were significantly higher among the urine and pulmonary source bacteremia isolates (median, 8.0; P , :001) and somewhat higher among the "other source" bacteremia isolates (median, 5.0) than among the ECOR fecal controls (median, 3.0).
With respect to phylogenetic background, compared with the 29 (preponderantly phylogenetic group A) human fecal ECOR strains, both the urine/pulmonary source and the "other source" bacteremia isolates were more likely to derive from phylogenetic group B2 (P , :001 and P ¼ :03, respectively) and less likely to derive from phylogenetic group A (P , :001 and P ¼ :02, respectively). Of note, the pulmonary source isolates and urinary source bacteremia isolates each differed significantly from the ECOR controls with respect to the prevalence of phylogenetic group B2 (P , :001, both bacteremia groups) or phylogenetic group A (urine source, P , :001; pulmonary source, P ¼ :008).
Host compromise status. The types of host compromise analyzed (overall prevalence) included local compromise (34%), severe alcoholism (21%), immune defects (35%), and "any compromise" (i.e., any of the above; 65%). In the total population, local compromise was significantly negatively associated with both iha and iut (aerobactin) (table 4). Stepwise multivariate logistic regression analysis confirmed iut as a significant independent negative predictor of local compromise, whereas sfa/foc replaced iha as the second most predictive variable (table 5) . Several other VGs exhibited borderline univariate associations with local compromise ( papG allele II, negative; K1, ibeA [invasion of brain endothelium A], and F14 papA allele, positive), alcoholism (F8 papA allele, positive), immune defects (cdtB [cytolethal distending toxin], negative), or any compromise (F13 papA allele, negative) (data not shown; all :01 , P , :05). The F8 and F12 papA alleles also exhibited borderline multivariate associations with alcoholism (ORs 5.8 and 6.6, respectively; both :01 , P , :05).
Because the distribution of bacterial characteristics was dependent on the primary source of bacteremia (table 1), the above analysis was repeated for subsets of bacteremic isolates from different primary sources of infection. This revealed new sets of associations (tables 4 and 5). Among the urine and pulmonary source isolates, in univariate analysis local compromise was significantly negatively associated with iut, whereas "any compromise" was negatively associated with both malX and papG allele II (only) (table 4). Stepwise multivariate logistic regression analysis indicated that, among the urine/pulmonary source isolates, both iut and focG significantly predicted absence of local compromise, whereas papG allele II (only) significantly predicted absence of "any compromise" (table 5) . Other VGs exhibited borderline univariate trends toward associations with either local compromise ( focG, iha, iroN, and papG allele II [only], negative; F14 papA allele, positive; all :01 , P , :05) or "any compromise" ( focG, iroN, and papG allele II [only], negative; all :01 , P , :05). The F13 papA allele was a borderline multivariate predictor of absence of "any compromise" (OR, 0.14; P ¼ :03).
In contrast, among the nonurine, nonpulmonary source isolates, in univariate analysis, alcoholism was positively associated with kpsMT II, and "any compromise" was negatively associated with papG allele III (table 4). Likewise, in stepwise multivariate logistic regression analysis, papG allele III significantly predicted absence of both immune defects and "any compromise" (table 5). Other VFs exhibited borderline univariate trends toward a negative association with immune defects (cnf1 and papG allele III; both :01 , P , :05) or borderline multivariate trends as predictors of absence of immune defects ( papG allele III; OR, 0.12; P ¼ :05) or presence of alcoholism (kpsMT II; OR, 12.0; P ¼ :02).
Aggregate VG scores in the total population were somewhat lower in the presence than in the absence of each compromising condition, with local compromise yielding the greatest overall Table 4 . Distribution of virulence-associated genes (VGs), according to host compromise status, among 182 Escherichia coli blood isolates from patients with diverse-source bacteremia. difference (median VG score 6.8 with local compromise vs. 8.0 without local compromise; P ¼ :04). Similar borderline trends were observed separately among both the urine/pulmonary source isolates and the "other source" isolates (data not shown).
In sum, VGs exhibiting significant negative associations with >1 type of host compromise in at least 1 analysis included iut, papG allele II, papG allele III, focG, iha, malX, and sfa/foc, and similar borderline trends were observed with the F13 papA allele, iroN, cdtB, and cnf1. In contrast, only kpsMT II was significantly positively associated with any type of host compromise, and similar borderline trends were observed only with the F14 and F8 papA alleles, the K1 kpsMT variant, ibeA, and the F12 papA allele. Altogether, significant negative associations of VGs with host compromise outnumbered positive associations by a ratio of 12:1 (P , :01, McNemar's test), and for similar borderline associations this ratio was 13:8.
As for host compromise in relation to phylogenetic group, in the total population, compared with cluster III isolates, non-cluster III isolates exhibited a slightly greater prevalence of both immune defects and "any compromise" (data not shown). Among the urine/ pulmonary source isolates, non-cluster III isolates exhibited a significantly higher prevalence of "any compromise" (16/16 vs. 47/ 69 [68%]; P ¼ :009) and a somewhat higher prevalence of local compromise (12/16 [75%] vs. 34/69 [49%]). Among the "other source" isolates, no associations of phylogenetic background with host compromise were evident (data not shown).
Community versus hospital acquisition of bacteremia. Comparisons between isolates from community-acquired versus hospital-acquired bacteremia episodes showed that, in the total population, iut was significantly associated with community acquisition (table 6) . iha exhibited a similar trend, whereas ibeA exhibited a borderline association with hospital acquisition (data not shown; :01 , P , :05 for both). Stepwise multivariate logistic regression analysis confirmed iut as the sole significant independent predictor of community acquisition (for hospital acquisition, OR, 0.37; P ¼ :002) and replaced ibeA with the F8 papA allele as a borderline predictor of hospital acquisition (OR, 7.4; P ¼ :02). Aggregate VG scores were slightly higher among the community-acquired versus hospital-acquired bacteremia isolates (median score, 7.0 vs. 6.3, respectively).
After stratification according to primary source of bacteremia, among the urine/pulmonary source isolates, iut was still associated with community acquisition (table 6), whereas iha and malX exhibited similar borderline trends (:01 , P , :05 for both). In stepwise multivariate logistic regression analysis, iut alone approached statistical significance as an independent predictor of community-source bacteremia (for hospital acquisition, OR, 0.34; P ¼ :015), whereas malX was a weaker borderline predictor (for hospital acquisition, OR, 0.31; P ¼ :04). Aggregate VG scores again were somewhat higher among community-acquired, compared with hospital-acquired, isolates (median, 8.0 vs. 6.3).
In contrast, among the "other source" isolates, only malX exhibited even a borderline association with hospital versus community acquisition in the univariate or multivariate analyses, and in both analyses it weakly predicted hospital origin (univariate, P ¼ :04; multivariate, OR, 2.82; P ¼ :04). Aggregate VG scores among the "other source" isolates showed a trend opposite to that observed among urine/pulmonary isolates, with hospitalacquired isolates now exhibiting somewhat higher scores than community-acquired isolates (median, 6.4 vs. 5.0). Consequently, VG scores differed significantly according to source of bacteremia among community-acquired isolates (median VG score, 8.0 urine/pulmonary vs. 5.0 others; P , :001) but not among nosocomial isolates (median score, 6.3 vs. 6.4; P . :10).
In sum, the only VG that yielded significant associations with community versus hospital origin of bacteremia was iut (community origin), whereas borderline associations were observed with iut and malX (community origin) and with the F8 papA allele, ibeA, and malX (hospital origin). Associations of VGs with community origin outnumbered those with hospital origin by 3 to 0 for significant associations and by 6 to 3 for borderline associations. a Only those types of host compromise that yielded associations P < :01 are shown.
b Only those VGs that yielded P < :01 when added to the model are shown. Additional VGs yielded P < :01 when removed from, but not when added to, the model (data not shown).
c Parentheses indicate negative associations of VGs with host compromise.
Interactions among host variables. Because certain VFs exhibited associations with multiple clinical variables, possible confounding was assessed by testing for associations among the clinical variables. No significant or borderline associations were observed between any 2 of the 3 major clinical variables-clinical source of bacteremia, host compromise status (analyzed separately for local compromise, immune compromise, alcoholism, or "any compromise"), or hospital versus community origin of bacteremia-either in the total population or with stratification according to the remaining clinical variable (data not shown).
Discussion
In the present study, we explored associations between bacterial traits and host characteristics among 182 extensively characterized E. coli blood isolates from patients with diverse-source bacteremia [18, [23] [24] [25] . We found evidence of a continuum of virulence, from urinary and pulmonary source bacteremia isolates, through other source bacteremia isolates, to fecal isolates, with a corresponding graded phylogenetic distribution from group B2 to groups A and B1. We also found that, although associations of bacterial traits with host compromise and hospital versus community origin of infection varied considerably, depending on subgroup and statistical method, certain VGs (including several nontraditional markers) repeatedly emerged as epidemiological predictors, which suggests their possible relevance in pathogenesis.
Our first major finding was the novel demonstration that pulmonary source bacteremia isolates closely resemble urinary source isolates with respect to VG profiles and phylogenetic background. This supports the hypothesis that many of the VGs that traditionally have been regarded as encoding "urovirulence factors" actually may contribute to virulence at other extraintestinal sites rather than being specific to the urinary tract [10, 32] . The urine and pulmonary source isolates differed from the "other source" bacteremia isolates by exhibiting a greater prevalence of multiple VGs, higher aggregate VG scores, and a greater preponderance of phylogenetic group B2-derived members-evidence that suggests that they are more virulent (according to conventional in vitro criteria) than the "other source" bacteremia isolates. Still, the "other source" isolates exhibited analogous differences with respect to pathotype and phylogenetic background in comparison with the fecal control group. This suggests the existence of a continuum of extraintestinal virulence, with urine and pulmonary source bacteremia isolates at one extreme (high virulence), fecal isolates at the other extreme (low virulence), and "other source" bacteremia isolates in an intermediate position.
These findings provide novel evidence of diverse urovirulenceassociated characteristics among E. coli clinical isolates from patients with a defined primary site of extraintestinal infection other than the urinary tract or central nervous system. They thus support the concept of ExPEC as a distinctive subset of the E. coli population with a special ability to cause extraintestinal disease at diverse anatomical sites [10] .
Experimental support for certain putative "urovirulence factors" (e.g., lipopolysaccharide, capsule, and cytotoxic necrotizing factor) as contributors to virulence at nonurinary extraintestinal sites also is available from animal models [33, 34] . Further work in this area is needed to assess a broader range of putative extraintestinal virulence factors as possible "generalists" with respect to anatomical site and clinical syndrome. Further epidemiological investigation also is needed to determine whether the associations observed in this bacteremia population apply also to nonbacteremic infections at the same primary sites [35] [36] [37] . It is likely that the requirement for invasion of and survival within the bloodstream imposed by the entry criteria for this study (i.e., a positive blood culture) biased the present study population toward a more virulent, or at least a more "bacteremia competent," subset of the spectrum of pathotypes that can infect the various body sites that served as the primary sources for the bacteremia episodes [23] . Pending further molecular epidemiological surveys or direct experimental evaluation, the findings of this study should not be presumed to apply generally to all nonurinary extraintestinal E. coli isolates.
A second major finding was that associations of bacterial factors with host characteristics are highly complex and vary considerably depending on the clinical context (i.e,. primary source of bacteremia), the specific host characteristic considered (e.g., the various forms of host compromise), and the analytical approach used (e.g., univariate vs. multivariate analysis). Such variability suggests that different groups of bacterial traits are pathogenetically relevant in different epidemiological settings, such that a particular trait's contribution to pathogenesis may vary depending on the host and setting. Valid global generalizations regarding these relationships thus may be difficult to derive, because the relationships appear to be highly context dependent. This context dependence may contribute to the seemingly discrepant findings of different studies with respect to the effect of various forms of host compromise on the prevalence of specific bacterial virulence traits in extraintestinal E. coli infections. An example of such a discrepancy is the association of papG allele III with host compromise among isolates from patients with urosepsis or febrile UTI isolates in other studies [22, 38] but not in the present study, which, in contrast, found the papG allele III to be significantly associated with absence of host compromise but only among "other source" isolates.
Our third major finding was that, despite this considerable variability, certain consistent themes emerged. For example, significantly more negative than positive associations were identified between VGs and host compromise, and similar trends were observed for associations of VGs with hospital versus community acquisition of infection. This is consistent with the hypothesis that the VG products help overcome host defenses and hence are less necessary when host defenses are impaired [8, 17] , as often is true for hospitalized patients. In addition, multiple VGs, which typically represent different functional classes of virulence factors (e.g., adhesins, toxins, and siderophores), were sometimes inde-pendently associated with the same epidemiological outcome variable (tables 4 and 5). This supports a multifactorial model of virulence in ExPEC, according to which combination of virulence factors, as are typically present in the most virulent ExPEC strains, must act sequentially or in concert for full pathogenicity [17] . The observed differences in VF repertoire between hospital-and community-acquired bacteremia isolates, irrespective of the primary source of bacteremia, also suggest that different selection factors operate and/or different background bacterial populations exist in these 2 environments [39, 40] .
Negative associations of VGs with host compromise, the most frequently observed pattern, are readily explained mechanistically as a reduced requirement for the particular VG when a relevant host defense system is impaired [8] . Less clear is the basis for a positive association of a VG with host compromise, such as the association of kpsMT II with alcoholism among "other source" isolates (table 4) . This phenomenon might indicate that the particular type of host compromise weakens a defense mechanism that normally protects specifically against the particular virulence factor. For kpsMT II and alcoholism, this would suggest a special vulnerability of severe alcoholics to infection with encapsulated organisms, which is consistent with the known associations of alcoholism with Klebsiella pneumonia and pneumococcal disease.
However, despite the observed significant differences in VG repertoire between isolates from compromised versus noncompromised hosts and between nosocomial versus community-acquired isolates, for each epidemiological variable most VGs were similarly prevalent in both comparison populations. This indicates that, to the extent that the "conserved" VGs encode true pathogenetically relevant virulence factors, vaccines or other interventions directed against these factors should be broadly applicable in diverse host populations and diverse clinical contexts [8, [41] [42] [43] [44] [45] .
A final important point of consistency amid the observed variability was the repeated emergence of certain bacterial traits (e.g., iut, malX, focG, and papG alleles II and III) as significant or borderline correlates of clinical variables, including primary site of infection, host compromise status, and hospital versus community acquisition of bacteremia. The repeated identification of these "high profile" traits as epidemiological predictors suggests either that the traits themselves participate directly in host-pathogen interactions (which would make them potential targets for preventive interventions) or that they are closely linked with other traits that do so [46, 47] . The latter seems likely for VGs such as malX, which has no known direct role in virulence; yet, in the present study it equaled papG allele II and was exceeded only by iut with respect to the number of significant associations it exhibited with clinical parameters (i.e., 3 significant associations each for malX and papG allele III and 7 for iut ). Indeed, malX was included in the survey primarily as a marker for a PAI from archetypal ExPEC strain CFT073 [26, 48, 49] . Yet, in several analyses, malX took statistical precedence over other more traditional VGs (e.g., hly ) known to reside on the same PAI in strain CFT073 as malX [48, 49] . This suggests that (1) malX may have served as a proxy for a combination of such linked VGs, (2) there are currently undiscovered VGs on malX-associated PAIs that are even more potent determinants of virulence than the recognized malX-associated VGs, or (3) malX itself participates significantly in host-pathogen interactions [21, 23, 26, 28, 50, 51] .
Indeed, of the significant and borderline associations detected in the present study, nearly as many involved "nontraditional" VGs as involved more conventional VGs. The "nontraditional" VGs of note were of several varieties, including (1) newly described VGs (e.g., iroN, iha, and fyuA ), (2) marker VGs (e.g., malX ), and (3) subtypes of traditional VGs, including focG as a subtype within the sfa/foc adhesin family and the various papG and papA alleles as subtypes within the pap adhesin family. The detection of so many associations involving the "nontraditional" VGs demonstrates the epidemiological importance of these VGs in comparison with traditional VGs and validates our simultaneously broad and discriminating approach to molecular epidemiological analysis. Because additional putative extraintestinal VGs are discovered through whole-genome sequencing, analysis of PAIs [5, 48, 49, [52] [53] [54] , subtractive hybridization [55] , signature-tagged mutagenesis [34] , and other contemporary molecular techniques [56, 57] , molecular epidemiologists will be increasingly challenged by the growing number of potential targets for inclusion in future population surveys.
Overall, the most frequently identified specific predictor VG was iut. Although the aerobactin system has been studied as a putative extraintestinal virulence factor for . 20 years [8, 58] , only recently has a direct role for iut in urovirulence been confirmed by use of an isogenic knockout mutant [59] . Because the secreted aerobactin molecule itself [60] or the outer membrane aerobactin receptor [61] should be accessible vaccine targets and because one of the enzymatic steps in aerobactin biosynthesis is unique to bacteria and hence potentially amenable to inhibition with bacteria-specific chemotherapy [62] , several anti-aerobactin preventive measure can be envisioned.
A limitation of the present study that results from its broad scope is the use of multiple comparisons. This increases the chance of a type I error-that is, a false conclusion of a significant difference [63] . To protect against type I errors, we used a more stringent than usual criterion for statistical significance and considered the consistency of the findings across statistical methods and with different stratifications of the data set [64, 65] . Nonetheless, the findings must be regarded as suggestive rather than definitive. Another limitation is the (previously demonstrated) considerable interdependence of many of the bacterial traits analyzed, which confounds multivariate analysis. The partial regression coefficient associated with each predictor variable depends on other predictor variables in the regression model, such that the importance of a given bacterial trait may be unfairly discounted when another strongly correlated trait has already been included in the model. Similarly, the absolute con-finement of certain bacterial traits to specific subgroups within the population, although yielding highly significant univariate associations, resulted in computational artifacts in the multivariate analyses (data not shown) that precluded recognition of these traits as significant predictors in stepwise logistic regression.
That only 11 of the subjects were women precluded meaningful analysis of sex in relation to bacterial characteristics. It would be desirable for future analysis to assemble a more balanced collection of isolates from a mixed-sex population that includes not only patients with bacteremia but also those with localized infections at various anatomical sites for comparison with concurrent fecal isolates from the same patients, from noninfected patients, and/or from health care workers. Prospective capture of specifically defined clinical and epidemiological data elements, including aspects of the clinical presentation and response to therapy, would permit testing of hypotheses generated by the present study and exploration of many additional hypotheses regarding the relationship among putative VFs, host characteristics, and clinical outcomes.
In summary, we defined associations between bacterial traits and host characteristics among 182 extensively characterized E. coli blood isolates from patients with diverse-source bacteremia. We found evidence of a continuum of virulence from urinary and pulmonary source bacteremia isolates, through other source bacteremia isolates, to fecal isolates, with a corresponding graded phylogenetic distribution from group B2 to groups A and B1. Although associations of bacterial traits with syndrome, host compromise, and hospital versus community origin of bacteremia varied considerably, depending on subgroup and statistical method, certain VGs (including iut and several nontraditional VGs such as the PAI marker malX ) repeatedly emerged as predictors, which suggests their possible relevance in pathogenesis. These findings support the concept of ExPEC as a functionally relevant subset of the E. coli population with enhanced virulence potential at diverse extraintestinal sites. They also identify specific bacterial traits for future investigation as possible direct participants in host-pathogen interactions during E. coli bacteremia and hence as potential targets for protective interventions.
